Navigation Links
Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
Date:10/16/2009

BURLINGTON, Mass., Oct. 16 /PRNewswire-FirstCall/ -- Palomar Medical Technologies Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced the termination of its agreement with Johnson & Johnson Consumer Companies Inc ("JJCC"), a Johnson & Johnson company, to develop, clinically test and commercialize home-use, light-based devices for (i) reducing or reshaping body fat including cellulite; (ii) reducing appearance of skin aging; and (iii) reducing or preventing acne. Despite Palomar having met all of its deliverables under the agreement, JJCC terminated the agreement referencing the current unfavorable economic conditions as the reason for its decision. With this decision, JJCC avoids having to make a large commercialization payment to Palomar and avoids having to commit to the significant level of funding required to successfully launch a new product into the mass market. Upon termination of the agreement, JJCC's license to Palomar technology was terminated and all technology and intellectual property rights related to light-based devices developed under the agreement were assigned to Palomar. JJCC is also precluded from further development or commercialization of the light-based devices developed under the agreement.

Palomar will continue with the commercialization of the light-based devices developed under the agreement. In June 2009, Palomar was the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home-use, laser device for the treatment of periorbital wrinkles. OTC clearance allows this wrinkle treatment device to be marketed and sold directly to consumers without a prescription. This consumer wrinkle treatment device was developed by Palomar and completed toget
'/>"/>

SOURCE Palomar Medical Technologies Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
2. Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer
3. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
4. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
5. ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
6. Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth
7. Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
8. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
9. Pelleve(TM) Wrinkle Treatment System Featured On Beauty Spaces TV Show
10. Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
11. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or ... Small Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) ... Diseases (NIAID), a division of the National Institutes ... human antibody therapeutics to combat Staphylococcus aureus ... including methicillin-resistant S. aureus (MRSA), was ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip.  Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22.  ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group ... for their competitive landscape map for the Chronic ... over 90 international companies with drugs and devices ... CKD and its sequelae. (Logo:  ... , hypertension - renal denervation ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2
... Call to discuss the company,s third quarter financial ... 11:00 a.m. EDT (8:00 a.m. PDT). SUNNYVALE, Calif., ... PCYC ) today announced that it has entered ... leading French independent pharmaceutical company. The alliance will ...
... TLR8 Agonist to Advance for Treatment of AllergySAN DIEGO ... biopharmaceutical company focused on the development of novel Toll-Like ... respiratory and inflammatory diseases, announced today that it has ... selective intranasal TLR8 agonist for the treatment of allergic ...
Cached Medicine Technology:Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 2Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 3Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 4Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 5VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2
(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...
(Date:5/18/2013)... Angeles, Ca (PRWEB) May 18, 2013 Losing ... of people. But among the horde of new weight loss ... one most talked about. Recent studies about this newest weight ... achieve one’s ideal body shape. , Garcinia Cambogia is a ... like a tamarind. Eating the fruit can suppress a person’s ...
(Date:5/18/2013)... 18, 2013 John Ravera, D.D.S., a ... of a new member to his dental team, Courtney Marino. ... the field for over 10 years. She received her degree ... was elected a member of Sigma Pi Alpha, a national ... enjoys working with patients of all ages, helping them understand ...
(Date:5/18/2013)... Provo, UT (PRWEB) May 18, 2013 Medical ... pre-launch orders for its much anticipated mobility aid with its ... to create a hands-free crutch alternative that injured ... a broken ankle, for example, can remain active and walk ... team is using its reservation system to ensure those who ...
(Date:5/17/2013)... Salt Lake City, Utah (PRWEB) May 17, 2013 ... muscle by providing their corporate wellness programs to ... system. This has been achieved through rigorous ... into a greater capacity for employee interactions via ... specializes in helping businesses lower employee healthcare ...
Breaking Medicine News(10 mins):Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant 2
... Wellness Festival with ... at 10 a.m., BOSTON, May 31 Cyndi Lauper, in ... from her rehearsal,on Friday night to meet with some of this ... http://www.newscom.com/cgi-bin/prnh/20080531/CLSA004 ), The 23rd Annual AIDS Walk Boston ...
... SAN CLEMENTE, Calif., May 30 Hero Nutritionals,introduced Slice ... adults, at,the Natural Products Expo West in March 2008. ... Coenzyme Q10. Though CoQ10 is found in every cell ... from the word,ubiquitous for ,found everywhere, low levels of ...
... World Report has ranked,Cincinnati Children,s Hospital Medical Center the ... pediatrics in the 2008 edition of,its annual "America,s Best ... has ever received from U.S. News., "This is ... debt of thanks,to the thousands of employees who helped ...
... 30 The National Alliance on,Mental Illness (NAMI) ... to public education about mental illness at NAMI,s ... NAMI executive director Mike Fitzpatrick made the announcement ... which he discussed the premiere of,two television documentaries ...
... BOSTON, May 30 The following is being issued,by the ... 1,200 physician scientists from 58 countries across the globe, ... When: Wednesday, June 4-Monday, June 9, Where: Boston ... To accelerate science that improves patient care, Wednesday, June ...
... Deadline is Dec. 31, but FDA urges asthma patients ... 30 (HealthDay News) -- Asthma inhalers that contain the ... that harm the ozone layer. And these inhalers won,t ... are urging patients to switch to alternative inhalers now. ...
Cached Medicine News:Health News:Sunday's AIDS Walk Boston at the Esplanade Gets Tribute from Cyndi Lauper at True Colors Concert Tour Launch Rehearsal 2Health News:U.S. News Ranks Cincinnati Children's Among Top Three U.S. Children's Hospitals 2Health News:U.S. News Ranks Cincinnati Children's Among Top Three U.S. Children's Hospitals 3Health News:NAMI Blog: PBS, MTV and Jane Pauley 2Health News:World-Renowned Scientists to Lead Immunology Course 2Health News:World-Renowned Scientists to Lead Immunology Course 3Health News:World-Renowned Scientists to Lead Immunology Course 4Health News:Ozone-Depleting Inhalers Being Phased Out 2Health News:Ozone-Depleting Inhalers Being Phased Out 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: